Hypophosphatemic Rickets in Norway

Haukeland University Hospital

Status: Unknown

Conditions: Rickets; Hypophosphatemia, Familial; Hyperphosphatemia

Treatments: Drug: Sevelamer; Dietary Supplement: Alfacalcidol; phosphate.

Study type: Observational

Funder types: Other

Identifiers

NCT01057186

21922

Details and patient eligibility

About

The purpose of the study is to do a follow-up survey of all individuals with hereditary hypophosphatemia in Norway, focusing on manifestations in childhood and adolescence. The investigators also want to study phenotype-genotype associations, and look for new genes, in all forms of hereditary hypo and hyperphosphatemia.

Enrollment: 80 estimated patients

Sex: All

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• All patients in the Norwegian population with hereditary hypophosphatemia, with or without rickets
• Patients in the Norwegian population with hereditary hyperphosphatemia

Exclusion criteria

Trial design

80 participants in 2 patient groups

hereditary hypophosphatemia

Description:

Norwegian patients with hereditary hypophosphatemia.

Treatment:

Dietary Supplement: Alfacalcidol; phosphate.

Hereditary hyperphosphatemia

Description:

Norwegian patients with hereditary hyperphosphatemia (hyperphosphatemic familial tumoral calcinosis and hyperphosphatemia hyperostosis syndrome).

Treatment:

Drug: Sevelamer